Navigation

Press releases

The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.

Results 81-90 of 854

NICE consults on draft guidance recommending tests to help diagnose and treat asthma
NICE has published draft diagnostics guidance for public consultation which recommends 3 non-invasive tests for measuring the concentration of nitric oxide in a person's breath. Levels of this gas are higher in people with asthma than other people.
November 7, 2013

Following simple steps can help reduce surgical-site infections, saving lives and money, says NICE in new standards
The National Institute for Health and Care Excellence (NICE) has issued standards to help prevent and treat surgical site infection in adults, children and young people undergoing surgical incisions through the skin.
October 31, 2013

NICE gives green light to ranibizumab for eye condition in final draft guidance
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending ranibizumab (Lucentis, Novartis) as a treatment option for sight problems caused by new blood vessels growing at the back of the eye in people with a rare form of short-sightedness known as pathological myopia
October 25, 2013

Families need more help to tackle obesity in youngsters
The organisation that sets standards of excellence in health and social care, NICE, has called on local authorities and health professionals to do more to help families address the obesity time-bomb in children and young people.
October 23, 2013

NICE says yes to eye condition treatment in final guidance
NICE has published final guidance recommending ocriplasmin (Jetrea, ThromboGenics) as an option for treating some people with the rare eye condition, vitreomacular traction.
October 23, 2013

NICE draft guidance update on hip replacement and resurfacing recommends more reliable artificial joints
NICE is updating its guidance on hip replacements and hip resurfacing. The updated draft recommendations include a stricter benchmark for the quality of hip prostheses, proposing that the new joint should work well in at least 95% of cases over 10 years, instead of the current 90% of cases.
October 18, 2013

NICE says yes to new prostate cancer drug
NICE has issued new draft guidance recommending enzalutamide (Xtandi, Astellas Pharma) as an option for treating hormone relapsed metastatic prostate cancer in adults
October 18, 2013

New draft guidance on lifestyle weight management services
The National Institute for Health and Care Excellence (NICE) has begun a consultation on draft guidance on lifestyle weight management services available to help overweight and obese people to achieve and maintain a healthier weight.
October 16, 2013

NICE consults again on non-Hodgkin's lymphoma treatment
NICE has launched a second consultation on draft guidance for a drug to treat an aggressive form of lymphoma, which is a cancer that develops in the body's immune system.
October 15, 2013

NICE final draft guidance recommends drugs to treat chronic hepatitis C in children and young people
In final draft guidance NICE has confirmed its earlier draft guidance recommending peginterferon alfa in combination with ribavirin as an option for treating chronic hepatitis C in children and young people.
October 11, 2013

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.